Chromatin Bio Awarded Scottish Enterprise SMART grant

October 4, 2024

Award extends company's activities in AI/ML

We are pleased to announce that Scottish Enterprise have awarded Chromatin Bio £100,000 to fund a project that aims to extend the company's platform with the introduction of a suite of AI/ML tools.


Chromatin Bio has created an integrated platform that is able to process a variety of NGS datasets and identify cell-selective and conditionally active gene regulatory elements. Then using engineering biology principles, the company can build synthetic promoters utilising these elements and create customised gene expression cassettes for its clients.


Currently the company offers this service to cell and gene therapy companies wishing to improve therapeutic construct design. Although the platform is broadly applicable across the entire biotech industry, including bio-manufacturing, industrial biotech and agriculture.


The introduction of machine learning pipelines into this process will greatly increase the efficiency of gene regulatory element discovery and improve the potency of the synthetic promoter designs, resulting in improved expression cassettes for our partners.

By Michael Roberts March 11, 2025
March 18-19, 2025 | London, UK
By Michael Roberts February 20, 2025
EDINBURGH, Scotland, Feb. 20, 2025
By Michael Roberts January 20, 2025
We are thrilled to be working with Johnson & Johnson, a leader in global healthcare innovation.
By Michael Roberts January 12, 2025
January 29-30, 2025 | London, UK
By Michael Roberts January 3, 2025
January 20-23, 2025 | Dallas, Texas
By Michael Roberts October 22, 2024
Oct 22-25, 2024 | Rome, Italy
By Michael Roberts September 24, 2024
Nov 4-6, 2024 | Stockholm, Sweden
By Michael Roberts September 17, 2024
Our New Principal Bioinformatics & AI/ML Engineer
By Michael Roberts April 3, 2024
May 7-11, 2024 | Baltimore, MD, USA
More Posts
Share by: